Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
Factor | p | OR | 95% CI | p | OR | 95% CI |
Gender (male vs. female) | 0,126 | 0,42 | 0,13–1,28 | |||
Age (years) (<54 vs. ≥55) | 0,056 | 3,3 | 0,97–11,26 | |||
Disease duration (years) (<5 vs. ≥5) | 0,941 | 1,04 | 0,34–3,19 | |||
T stadium (T1 and T2 vs. T3 and T4) | 0,03 | 4,18 | 1,14–15,19 | |||
N stadium (N0 and Nx vs. N1a and N1b) | 0,451 | 2,19 | 0,28–16,98 | |||
Tumor type (minimally vs. widely invasive) | 0,684 | 0,78 | 0,24–2,54 | |||
Tumor size (mm) (≤39 vs. >40) | 0,328 | 1,99 | 0,49–7,99 | |||
Capsular invasion (positive vs. no or minimal) | 0,903 | 1,09 | 0,29–4,07 | |||
Vascular invasion (positive vs. no or minimal) | 0,149 | 0,22 | 0,03–1,71 | |||
Number of tumor focuses (one vs. multicentric) | 0,374 | 1,72 | 0,52–5,73 | |||
Affection of both lobes (yes vs. no) | 0,05 | 3,09 | 0,97–9,85 | 0,002 | 8,09 | 2,12–30,79 |
Regional tumor infiltration (yes vs. no) | 0,027 | 0,28 | 0,92–0,86 | |||
Primary procedure (total thyroidectomy vs. less than total) | 0,049 | 3,24 | 0,99–10,64 | 0,002 | 8,46 | 2,21–32,31 |
Total thyroidectomy after lobectomy (yes vs. no) | 0,118 | 0,3 | 0,68–1,35 | |||
Type of procedure overall (total thyroidectomy vs. less than total) | 0,817 | 1,17 | 0,31–4,31 | |||
Reoperation due to relapse (yes vs. no) | 0,001 | 0,117 | 0,04–0,35 | 0,001 | 0,10 | 0,03–0,39 |
Surgeon’s experience (years) (<10 vs. 10+) | 0,421 | 0,63 | 0,2–1,95 | |||
Radioiodine ablation (yes vs. no) | 0,921 | 1,12 | 0,1–12,45 | |||
Diabetes mellitus (yes vs. no) | 0,603 | 21,78 | 0,001–2,393,431 | |||
Hypertension (yes vs. no) | 0,292 | 0,53 | 0,16–1,71 | |||
Other malignancies (yes vs. no) | 0,519 | 23,03 | 0,002–315,487 | |||
Thyroglobulin (ng/mL) (<300 vs. >300) | 0,695 | 1,62 | 0,14–18,38 |